Nature Communications (May 2024)

TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression

  • Marta Garcia-Montojo,
  • Saeed Fathi,
  • Cyrus Rastegar,
  • Elena Rita Simula,
  • Tara Doucet-O’Hare,
  • Y. H. Hank Cheng,
  • Rachel P. M. Abrams,
  • Nicholas Pasternack,
  • Nasir Malik,
  • Muzna Bachani,
  • Brianna Disanza,
  • Dragan Maric,
  • Myoung-Hwa Lee,
  • Herui Wang,
  • Ulisses Santamaria,
  • Wenxue Li,
  • Kevon Sampson,
  • Juan Ramiro Lorenzo,
  • Ignacio E. Sanchez,
  • Alexandre Mezghrani,
  • Yan Li,
  • Leonardo Antonio Sechi,
  • Sebastian Pineda,
  • Myriam Heiman,
  • Manolis Kellis,
  • Joseph Steiner,
  • Avindra Nath

DOI
https://doi.org/10.1038/s41467-024-48488-7
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 24

Abstract

Read online

Abstract TAR DNA-binding protein 43 (TDP-43) proteinopathy in brain cells is the hallmark of amyotrophic lateral sclerosis (ALS) but its cause remains elusive. Asparaginase-like-1 protein (ASRGL1) cleaves isoaspartates, which alter protein folding and susceptibility to proteolysis. ASRGL 1 gene harbors a copy of the human endogenous retrovirus HML-2, whose overexpression contributes to ALS pathogenesis. Here we show that ASRGL1 expression was diminished in ALS brain samples by RNA sequencing, immunohistochemistry, and western blotting. TDP-43 and ASRGL1 colocalized in neurons but, in the absence of ASRGL1, TDP-43 aggregated in the cytoplasm. TDP-43 was found to be prone to isoaspartate formation and a substrate for ASRGL1. ASRGL1 silencing triggered accumulation of misfolded, fragmented, phosphorylated and mislocalized TDP-43 in cultured neurons and motor cortex of female mice. Overexpression of ASRGL1 restored neuronal viability. Overexpression of HML-2 led to ASRGL1 silencing. Loss of ASRGL1 leading to TDP-43 aggregation may be a critical mechanism in ALS pathophysiology.